Cargando…

How to Differentiate Benign from Malignant Adrenocortical Tumors?

SIMPLE SUMMARY: Adrenocortical carcinoma is a rare cancer with a poor prognosis. Adrenal tumors are, however, commonly identified in clinical practice. Discrimination between benign and malignant adrenal tumors is of great importance to determine the appropriate treatment and follow-up strategy. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viëtor, Charlotte L., Creemers, Sara G., van Kemenade, Folkert J., van Ginhoven, Tessa M., Hofland, Leo J., Feelders, Richard A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431066/ https://www.ncbi.nlm.nih.gov/pubmed/34503194 http://dx.doi.org/10.3390/cancers13174383

Ejemplares similares

The Role of the IGF2 Methylation Score in Diagnosing Adrenocortical Tumors with Unclear Malignant Potential—Feasibility of Formalin-Fixed Paraffin-Embedded Tissue
por: Steenaard, Rebecca V., et al.
Publicado: (2023)

The Efficacy of Mitotane in Human Primary Adrenocortical Carcinoma Cultures
por: van Koetsveld, Peter M, et al.
Publicado: (2019)

Differentially Expressed Proteins in Malignant and Benign Adrenocortical Tumors
por: Kjellin, Hanna, et al.
Publicado: (2014)

MON-549 How Does the 2015 American Thyroid Association Risk Stratification System Perform in High Risk Thyroid Cancer Patients?
por: van Velsen, Evert, et al.
Publicado: (2019)

Evaluation of the 2015 ATA Guidelines in Patients With Distant Metastatic Differentiated Thyroid Cancer
por: van Velsen, Evert F S, et al.
Publicado: (2019)

The role of mTOR pathway as target for treatment in adrenocortical cancer
por: De Martino, Maria Cristina, et al.
Publicado: (2019)

Differentiating Benign from Malignant Adrenocortical Tumors by a Single Morphological Parameter—a Clinicopathological Study on 837 Adrenocortical Neoplasias
por: Walz, Martin K., et al.
Publicado: (2020)

Evaluating Disease-specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer
por: van Velsen, Evert F S, et al.
Publicado: (2022)

SAT-172 FDG PET/CT in Benign vs. Malignant Adrenocortical Tumors
por: He, Xin, et al.
Publicado: (2020)

Ang–Tie Angiogenic Pathway Is Distinctively Expressed in Benign and Malignant Adrenocortical Tumors
por: Oliveira, Sofia, et al.
Publicado: (2022)

Inhibin Alpha-Subunit (INHA) Expression in Adrenocortical Cancer Is Linked to Genetic and Epigenetic INHA Promoter Variation
por: Hofland, Johannes, et al.
Publicado: (2014)

Benign Adrenocortical Tumors and the Detection of Nonadrenal Neoplasia
por: Hao, Meng, et al.
Publicado: (2019)

Outcomes after Surgical Treatment of Metastatic Disease in the Adrenal Gland; Valuable for the Patient?
por: Metman, Madelon J. H., et al.
Publicado: (2021)

Genotype analysis of the human endostatin variant p.D104N in benign and malignant adrenocortical tumors
por: de Paula Mariani, Beatriz Marinho, et al.
Publicado: (2012)

ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase
por: Hofland, Johannes, et al.
Publicado: (2013)

IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer
por: De Martino, Maria Cristina, et al.
Publicado: (2019)

Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women
por: Blažević, Anela, et al.
Publicado: (2022)

Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours
por: Schmitz, K J, et al.
Publicado: (2011)

Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases
por: Wong, Cheuk-Lik, et al.
Publicado: (2022)

Effect of epigenetic treatment on SST(2) expression in neuroendocrine tumour patients
por: Refardt, Julie, et al.
Publicado: (2022)

Large Oncocytic Adrenocortical Tumor with Uncertain Malignant Potential
por: Lee, Chang Ki, et al.
Publicado: (2011)

GnRH antagonist treatment of malignant adrenocortical tumors
por: Doroszko, Milena, et al.
Publicado: (2018)

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
por: Klomp, M.J., et al.
Publicado: (2020)

Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives
por: Herrera-Martínez, Aura D., et al.
Publicado: (2018)

Epigenetic regulation of SST(2) expression in small intestinal neuroendocrine tumors
por: Klomp, Maria J., et al.
Publicado: (2023)

SUN-044 Methylation Status and Gene Expression of Steroidogenic Enzymes in Benign Adrenocortical Tumors
por: Di Dalmazi, Guido, et al.
Publicado: (2019)

Association between contralateral adrenal and hypothalamus-pituitary-adrenal axis in benign adrenocortical tumors
por: Zhu, Hongyuan, et al.
Publicado: (2023)

Adrenocortical Carcinoma and Synchronous Malignancies
por: Guerrero, Marlon A., et al.
Publicado: (2010)

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors
por: Altieri, Barbara, et al.
Publicado: (2016)

The Predictive Value of Golgi Protein 73 in Differentiating Benign from Malignant Liver Tumors
por: Bröker, Mirelle E. E., et al.
Publicado: (2014)

Benign and malignant tumors in Rubinstein–Taybi syndrome
por: Boot, Max V., et al.
Publicado: (2018)

Aberrant tryptophan metabolism in stromal cells is associated with mesenteric fibrosis in small intestinal neuroendocrine tumors
por: Blažević, Anela, et al.
Publicado: (2022)

Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
por: Sbiera, Iuliu, et al.
Publicado: (2021)

SUN-180 A Case of Deoxycorticosterone-Producing Malignant Adrenocortical Tumor
por: Cartolano, Natasha Scaranello, et al.
Publicado: (2020)

Value of MR imaging in the differentiation of benign and malignant orbital tumors in adults
por: Xian, Junfang, et al.
Publicado: (2010)

Contrast-Enhanced Ultrasonography in Differential Diagnosis of Benign and Malignant Ovarian Tumors
por: Qiao, Jing-Jing, et al.
Publicado: (2015)

Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver Tumors
por: Li, Bo, et al.
Publicado: (2017)

Peptide Receptor Radionuclide Therapy
por: Hofland, Johannes, et al.
Publicado: (2022)

Effects of Ketoconazole on ACTH-Producing and Non-ACTH-Producing Neuroendocrine Tumor Cells
por: Herrera-Martínez, Aura D., et al.
Publicado: (2019)

Adrenocortical Activity in Disseminated Malignant Disease in Relation to Prognosis
por: Bishop, M. C., et al.
Publicado: (1970)

Cannot write session to /tmp/vufind_sessions/sess_1vlnk7uacul5lq4q9ao504d9nh